1 This article is an editorial statement published in the Journal of the American Medical Association posted from August 2023.

Psychedelic Therapy—A New Paradigm of Care for Mental Health | Psychiatry and Behavioral Health | JAMA | JAMA Network

2 This article is from Cambridge University Press dated 2021.

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review | BJPsych Open | Cambridge Core

3 This 2021 article is from the journal Nature.

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study | Nature Medicine

4 This article is from the Journal of Psychopharmacology dated 2022.

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up - Natalie Gukasyan, Alan K Davis, Frederick S Barrett, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, Roland R Griffiths, 2022 (sagepub.com)

5. This article examines the efficacy of Psilocybin Vs. Escalopram in treating clinical depression is from The New England Journal of Medicine 2021.

Trial of Psilocybin versus Escitalopram for Depression | New England Journal of Medicine (nejm.org)

6. This landmark study was published in Psychopharmacology in 2006 demonstrated the safety and enduring positive effects of a single dose of psilocybin.

“Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance”

7. This study showed significant reductions in depression and anxiety in cancer patients following psilocybin treatment.

“Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial” .

8. Another article from the Journal of Psychopharmacology.

“Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial”

9.Promising tobacco cessation research from the Journal of Psychopharmacology.

“Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction”.


YOU CAN DISCOVER A WEALTH OF PSYCHEDELIC RESEARCH HERE

Disclaimer

The Ouroboros Foundation does not advocate for the illegal use of psychoactive substances. All information provided on this website is intended solely for educational purposes and harm reduction. Our mission is to support modern mental health research and promote safe, informed practices. Please consult with a healthcare professional before making any decisions related to your mental health and well-being.